These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24432151)

  • 21. Freedom and Responsibility in Synthetic Genomics: The Synthetic Yeast Project.
    Sliva A; Yang H; Boeke JD; Mathews DJ
    Genetics; 2015 Aug; 200(4):1021-8. PubMed ID: 26272997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequentialism and the Synthetic Biology Problem.
    Heavey P
    Camb Q Healthc Ethics; 2017 Apr; 26(2):206-229. PubMed ID: 28361719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Catastrophic Risk and the Drivers of Scientist Attitudes Towards Policy.
    Nathan C; Hyams K
    Sci Eng Ethics; 2022 Oct; 28(6):50. PubMed ID: 36305955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
    Ozdemir V; Faraj SA; Knoppers BM
    OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring global history through the lens of history of Chemistry: Materials, identities and governance.
    Roberts L
    Hist Sci; 2016 Dec; 54(4):335-361. PubMed ID: 28027707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized Medicine Across Disciplines and without Borders. Vural Özdemir speaks to Hannah Wilson, Commissioning Editor.
    Özdemir V
    Per Med; 2014; 11(7):687-691. PubMed ID: 26120345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enacting localist health policy in the English NHS: the 'governing assemblage' of Clinical Commissioning Groups.
    Hammond J; Coleman A; Checkland K
    J Health Serv Res Policy; 2018 Jan; 23(1):49-56. PubMed ID: 29256272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action learning for health system governance: the reward and challenge of co-production.
    Lehmann U; Gilson L
    Health Policy Plan; 2015 Oct; 30(8):957-63. PubMed ID: 25161271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Political and Governance Challenges to Achieving Global HIV Goals with Injecting Drug Users: The Case of Pakistan.
    Khalid H; Fox AM
    Int J Health Policy Manag; 2019 May; 8(5):261-271. PubMed ID: 31204442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Synthetic Biology and Biosafety Governance.
    Li J; Zhao H; Zheng L; An W
    Front Bioeng Biotechnol; 2021; 9():598087. PubMed ID: 33996776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsible, Inclusive Innovation and the Nano-Divide.
    Schroeder D; Dalton-Brown S; Schrempf B; Kaplan D
    Nanoethics; 2016; 10():177-188. PubMed ID: 27478517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Policy processes
    Jones CM; Clavier C; Potvin L
    Policy Sci; 2020; 53(1):161-180. PubMed ID: 32226161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The link between health governance models and global health innovation: an exploration of OECD nations.
    Schnarr K; Snowdon A; Cramm H; Cohen J; Alessi C
    Adv Health Care Manag; 2015; 17():39-69. PubMed ID: 25985508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticipating governance challenges in synthetic biology: Insights from biosynthetic menthol.
    Ribeiro B; Shapira P
    Technol Forecast Soc Change; 2019 Feb; 139():311-320. PubMed ID: 30774160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-poor governance in water and sanitation service delivery: evidence from Global Analysis and Assessment of Sanitation and Drinking Water surveys.
    Fuente D; Bartram J
    Perspect Public Health; 2018 Sep; 138(5):261-269. PubMed ID: 30015570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dioxin- and POP-contaminated sites--contemporary and future relevance and challenges: overview on background, aims and scope of the series.
    Weber R; Gaus C; Tysklind M; Johnston P; Forter M; Hollert H; Heinisch E; Holoubek I; Lloyd-Smith M; Masunaga S; Moccarelli P; Santillo D; Seike N; Symons R; Torres JP; Verta M; Varbelow G; Vijgen J; Watson A; Costner P; Woelz J; Wycisk P; Zennegg M
    Environ Sci Pollut Res Int; 2008 Jul; 15(5):363-93. PubMed ID: 18597132
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.